Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.58 |
| ▸ | DPP8 | Q6V1X1 | 18/20 | 0.58 |
| ▸ | DPP7 | Q9UHL4 | 10/20 | 0.52 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.52 |
| ▸ | FAP | Q12884 | 4/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5352004 | 0.94 | DPP4 (0.61) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL5345414 | 0.81 | CYP3A4 (0.52) | DPP4DPP8DPP7 | |
| SCHEMBL14558292 | 0.80 | DPP4 (0.61) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL6100492 | 0.79 | PREP (0.46) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3554780 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL3554784 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL14392573 | 0.74 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP | |
| Trifluoroacetic Acid SCHEMBL5347680 | 0.74 | DPP4 (0.57) | DPP4DPP8DPP7DPP9FAP | |
| Trifluoroacetic Acid SCHEMBL6921424 | 0.72 | DPP4 (0.52) | DPP4DPP8DPP7DPP9FAP | |
| SCHEMBL6453066 | 0.71 | DPP4 (1.00) | DPP4DPP8DPP7DPP9FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189728-B2 | Inhibitors of dipeptidyl peptidase IV | FERRING, BV (NL) | 2007-03-13 | — | — | US | disclosed |
| EP-1693365-A1 | Inhibitors of dipeptidyl peptidase IV | FERRING B.V. (NL) | 2006-08-23 | — | — | EP | disclosed |
| US-20030216450-A1 | Inhibitors of dipeptidyl peptidase IV | FERRING BV (NL) | 2003-11-20 | — | — | US | disclosed |
| EP-1282600-A1 | INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | Ferring BV (NL) | 2003-02-12 | — | — | EP | disclosed |
| WO-2001081304-A1 | INHIBITORS OF DIPEPTIDYL PEPTIDASE IV | FERRING BV (NL) | 2001-11-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216450-A1 | Inhibitors of dipeptidyl peptidase IV | DPP4, DPP7, DPP8 | DPP4 1/4885DPP8 3/4885DPP7 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.